Objective To investigate the methylation status of promoter region of PTEN,a tumor suppressor gene,in human thyroid papillary carcinoma cell lines.And to study the effects of 5-Aza-2'-deoxyglycoside(5-Aza-CdR),a demethylation agent,on the DNA methylation.To determine whether DNA methylation inhibitor can affect PTEN expression level through regulating its promoter methylation level.Providing a molecular basis for the molecular mechanism and treatment of papillary thyroid carcinoma.Method Methylation-specific PCR(MSP)and Quantitative Real-time PCR(Real-Time PCR)were used to detect the PTEN methylation status and PTEN m RNA expression in human thyroid papillary carcinoma B-CPAP and normal thyroid Nthy-ori-3 using 5-Aza-CdR or not.The relationship between PTEN gene methylation and thyroid papillary carcinoma cells was expolred.Results(1)There was only an amplified fragment of methylated primer in B-CPAP,and no any amplified fragment in Nthy-ori-3.(2)The brightness of the methylated amplified product of PTEN was decreased in B-CPAP cell treated with 5-Aza-CdR;(3)PTEN gene m RNA expressed in B-CPAP cells and lessly expressed in Nthy-ori-3 cells.(4)The PTEN m RNA expression was significantly increased in B-CPAP cells treated with 5-Aza-CdR.The difference was statistically significant difference between the two groups which treated with 5-Aza-CdR or not(P <0.05).Conclusion(1)There exists PTEN methylation in B-CPAP cell line,but not in Nthy-ori-3 cell line.(2)The expression of PTEN methylation was significantly decreased in B-CPAP cell line with 5-Aza-CdR treatment.(3)PTEN m RNA expression was significantly increased in B-CPAP cell line treated with 5-Aza-CdR;(4)Demethylation agent can significantly induce PTEN demethylation and promote its expression in thyroid cancer cells.5-Aza-CdR may play a therapeutic role. |